SANDU PHARMACEUTICALS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.5 INR | +0.44% |
|
-0.11% | -9.69% |
| 03-30 | Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer | CI |
| 03-30 | Sandu Pharmaceuticals Limited Announces Executive Changes | CI |
| Sales 2022 | 655M 7.85M 628M | Sales 2023 | 653M 7.83M 627M | Capitalization | 593M 7.11M 569M |
|---|---|---|---|---|---|
| Net income 2022 | 15M 180K 14.39M | Net income 2023 | 15M 180K 14.39M | EV / Sales 2022 | 0.88 x |
| Net cash position 2022 | 41.71M 500K 40.01M | Net cash position 2023 | 22.96M 275K 22.02M | EV / Sales 2023 | 0.87 x |
| P/E ratio 2022 |
37.6
x | P/E ratio 2023 |
32.4
x | Employees | 323 |
| Yield 2022 |
1.07% | Yield 2023 |
1.44% | Free-Float | 35.36% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.44% | ||
| 1 week | -0.11% | ||
| Current month | -0.11% | ||
| 1 month | -3.68% | ||
| 3 months | -14.61% | ||
| 6 months | -3.95% | ||
| Current year | -9.69% |
1 week
60.50
62.83
1 month
60.0069.00
Current year
55.1585.00
1 year
49.0085.00
3 years
37.2586.00
5 years
10.4586.00
10 years
8.3786.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 22/03/92 | |
| Compliance Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 31/05/11 | |
| Chief Executive Officer | 57 | 22/03/92 | |
| Director/Board Member | 78 | 31/03/15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/05/24 | 61.5 | +0.44% | 304 |
| 06/05/24 | 61.23 | -1.86% | 1,912 |
| 03/05/24 | 62.39 | +2.28% | 2,131 |
| 02/05/24 | 61 | -0.93% | 944 |
| 30/04/24 | 61.57 | -1.25% | 748 |
Delayed Quote Bombay S.E., May 07, 2024 at 11:00 am
More quotes
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.
Sector
Pharmaceuticals
Calendar
27/05/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.69% | 7.12M | |
| +43.96% | 6.34B | |
| -15.56% | 4.51B | |
| -6.52% | 3.29B | |
| +5.47% | 3.2B | |
| -0.76% | 2.59B | |
| +56.34% | 2.09B | |
| -4.11% | 1.76B | |
| +2.93% | 1.7B | |
| -8.02% | 1.62B |
- Stock Market
- Equities
- SANDUPHQ6 Stock
